As of 2026-04-02, the Relative Valuation of Dexcom Inc (DXCM) is 83.30 USD. This relative valuation is based on P/E multiples. With the latest stock price at 62.37 USD, the upside of Dexcom Inc based on Relative Valuation is 33.6%.
The range of the Relative Valuation is 66.93 - 112.22 USD.
| Range | Selected | |
| Trailing P/E multiples | 30.8x - 49.8x | 37.5x |
| Forward P/E multiples | 26.7x - 42.9x | 32.6x |
| Fair Price | 66.93 - 112.22 | 83.30 |
| Upside | 7.3% - 79.9% | 33.6% |
| Date | P/E |
| 2026-04-01 | 28.70 |
| 2026-03-31 | 28.90 |
| 2026-03-30 | 28.49 |
| 2026-03-27 | 28.65 |
| 2026-03-26 | 30.41 |
| 2026-03-25 | 30.76 |
| 2026-03-24 | 30.65 |
| 2026-03-23 | 30.35 |
| 2026-03-20 | 30.81 |
| 2026-03-19 | 30.96 |
| 2026-03-18 | 31.14 |
| 2026-03-17 | 30.98 |
| 2026-03-16 | 30.53 |
| 2026-03-13 | 29.56 |
| 2026-03-12 | 30.03 |
| 2026-03-11 | 30.52 |
| 2026-03-10 | 31.20 |
| 2026-03-09 | 31.63 |
| 2026-03-06 | 31.34 |
| 2026-03-05 | 32.53 |
| 2026-03-04 | 33.55 |
| 2026-03-03 | 33.63 |
| 2026-03-02 | 33.95 |
| 2026-02-27 | 33.79 |
| 2026-02-26 | 34.23 |
| 2026-02-25 | 33.67 |
| 2026-02-24 | 33.64 |
| 2026-02-23 | 33.71 |
| 2026-02-20 | 33.63 |
| 2026-02-19 | 33.26 |
| 2026-02-18 | 33.50 |
| 2026-02-17 | 32.41 |
| 2026-02-13 | 32.22 |
| 2026-02-12 | 29.95 |
| 2026-02-11 | 31.36 |
| 2026-02-10 | 31.37 |
| 2026-02-09 | 32.29 |
| 2026-02-06 | 32.20 |
| 2026-02-05 | 32.16 |
| 2026-02-04 | 32.59 |
| 2026-02-03 | 32.96 |
| 2026-02-02 | 33.38 |
| 2026-01-30 | 33.61 |
| 2026-01-29 | 34.05 |
| 2026-01-28 | 33.76 |
| 2026-01-27 | 33.90 |
| 2026-01-26 | 33.75 |
| 2026-01-23 | 33.53 |
| 2026-01-22 | 34.02 |
| 2026-01-21 | 33.18 |